Watching Genprex, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planFunding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC FilingsControl ChangeItem 5.01 · 8-KHIGH RiskMixed
Genprex, Inc.
Filed: Jul 29, 2026CIK: 0001595248
AI Executive Summary
AI-powered analysis of 8-K filing content
Genprex received a Nasdaq Hearings Panel exception to continue listing on The Nasdaq Capital Market despite not meeting the $1.00 minimum bid price requirement, with until December 7, 2026 to regain compliance. This allows the company to remain publicly traded while addressing its stock price challenges.
Key Takeaways
Nasdaq granted a compliance exception allowing Genprex to remain listed despite failing the $1.00 minimum bid price requirement
Company has until December 7, 2026 to demonstrate compliance with listing standards
2 more takeaways
Related Filings (1)
1 more filing from Genprex, Inc. in the last 90 days
Filing Overview
Form Type8-K
Filing DateJul 29, 2026
Item5.01
CategoryControl Change
CIK0001595248
Accession #gnpx20260730_8k.htm
Risk LevelHIGH
SentimentMixed
Signalrisk
Topics
regulatory
What This Means
Control of the company has changed. This could be through acquisition, proxy contest, or board restructuring.